Norepinephrine metabolites in plasma as indicators of pharmacological inhibition of monoamine oxidase and catechol O-methyltransferase.
Scheinin
M
M
Department of Pharmacology and Clinical Pharmacology, University of Turku, Finland.
Illi
A
A
Koulu
M
M
Ojala-Karlsson
P
P
D000978:Antiparkinson Agents / Q000494:pharmacology; D001549:Benzamides / Q000494:pharmacology; D015415:Biomarkers / Q000097:blood; D065098:Catechol O-Methyltransferase Inhibitors; D002396:Catechols / Q000494:pharmacology*; D002851:Chromatography, High Pressure Liquid; D006801:Humans; D008297:Male; D008734:Methoxyhydroxyphenylglycol / Q000031:analogs & derivatives* / Q000097:blood*; D020912:Moclobemide; D008995:Monoamine Oxidase / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009570:Nitriles; D009638:Norepinephrine / Q000031:analogs & derivatives / Q000097:blood*; D010422:Pentanones / Q000494:pharmacology; D012642:Selegiline / Q000494:pharmacology
D000978:Antiparkinson Agents; D001549:Benzamides; D015415:Biomarkers; D065098:Catechol O-Methyltransferase Inhibitors; D002396:Catechols; D008996:Monoamine Oxidase Inhibitors; D009570:Nitriles; D010422:Pentanones; D012642:Selegiline; C071192:entacapone; D008734:Methoxyhydroxyphenylglycol; C057364:nitecapone; D008995:Monoamine Oxidase; D020912:Moclobemide; C010117:3,4-dihydroxyphenylglycol; D009638:Norepinephrine